3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
11
Completed
10
Recruiting
3
Terminated
1
Not yet recruiting
1
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Neoplasm Metastasis
1
Lymphoma, B-Cell
1
Leukemia, Promyelocytic, Acute
1
Leukemia
1
Interventions
Tretinoin
1
Lisaftoclax
1
Arsenic Trioxide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Leukemia, Promyelocytic, Acute
×
Tretinoin
×
Clear all
NCT07296445
2025-12-29
LATITUDE
SDK Therapeutics, Inc.
Phase 3
Not yet recruiting
120 enrolled